Literature DB >> 8745324

Time course of membrane microarchitecture-driven neovascularization.

R F Padera1, C K Colton.   

Abstract

The host response to a microporous material that induces neovascularization at the material-tissue interface was studied in terms of the number and types of cells invading the membrane, the degree of vascularization at the material-tissue interface, and the characteristics of the surrounding connective tissue as a function of time following implantation. Millipore-MF mixed esters of cellulose membranes with a nominal pore diameter of 8.0 microns were implanted subcutaneously into male Sprague-Dawley rats and explanted at 3, 5, 7, 10, 21 and 329 days post-implantation. Two samples from each of two devices at each implantation time were embedded in paraffin, sectioned to a thickness of 5 microns, and stained with haematoxylin and eosin for light microscopic observation. The density of cells in the membrane increased up to 7 days following implantation, then remained roughly constant through 21 days and decreased at the 329 day time point. The vascularity of the material-tissue interface increased up to 10 days and remained at this level even at 329 days post-implantation. The connective tissue was disorganized, loose and avascular at 3 days, resembled granulation tissue at 5 days, and underwent fibrous capsule formation and maturation starting at 7 days following implantation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8745324     DOI: 10.1016/0142-9612(96)85565-7

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  13 in total

Review 1.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

2.  Evaluation of soft tissue coverage over porous polymethylmethacrylate space maintainers within nonhealing alveolar bone defects.

Authors:  James D Kretlow; Meng Shi; Simon Young; Patrick P Spicer; Nagi Demian; John A Jansen; Mark E Wong; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part C Methods       Date:  2010-06-04       Impact factor: 3.056

3.  Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection.

Authors:  Lori W Norton; Jaehyung Park; Julia E Babensee
Journal:  J Control Release       Date:  2010-06-02       Impact factor: 9.776

Review 4.  Engineering the vasculature for islet transplantation.

Authors:  Daniel T Bowers; Wei Song; Long-Hai Wang; Minglin Ma
Journal:  Acta Biomater       Date:  2019-05-23       Impact factor: 8.947

5.  Planar microdevices for enhanced in vivo retention and oral bioavailability of poorly permeable drugs.

Authors:  Hariharasudhan D Chirra; Ling Shao; Natalie Ciaccio; Cade B Fox; Jennifer M Wade; Averil Ma; Tejal A Desai
Journal:  Adv Healthc Mater       Date:  2014-04-07       Impact factor: 9.933

Review 6.  Manipulating the microvasculature and its microenvironment.

Authors:  Laxminarayanan Krishnan; Carlos C Chang; Sara S Nunes; Stuart K Williams; Jeffrey A Weiss; James B Hoying
Journal:  Crit Rev Biomed Eng       Date:  2013

7.  Permeability of subcutaneous tissues surrounding long-term implants to oxygen.

Authors:  Lucas S Kumosa; Timothy L Routh; Joe T Lin; Joseph Y Lucisano; David A Gough
Journal:  Biomaterials       Date:  2014-07-04       Impact factor: 12.479

8.  In vivo interaction of cells on poly L-(lactic acid) membranes containing plasticizer.

Authors:  D R M Silva; S M N Scapin; P P Joazeiro; M C Alberto-Rincon; R M Luciano; E A R Duek
Journal:  J Mater Sci Mater Med       Date:  2002-03       Impact factor: 3.896

Review 9.  Intraportal islet oxygenation.

Authors:  Thomas M Suszynski; Efstathios S Avgoustiniatos; Klearchos K Papas
Journal:  J Diabetes Sci Technol       Date:  2014-03-06

Review 10.  Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing.

Authors:  Kristy M Ainslie; Tejal A Desai
Journal:  Lab Chip       Date:  2008-09-19       Impact factor: 6.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.